# Cryoport

certified biosafety couriers with GDP, IATA DGR and ISO 21973 validation.

Source: https://en.bioecon.ru/companies/cryoport/
Updated: 2026-07-06

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | $176.2 million (2025-12-31) | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-022940/0001104659-26-022940.pdf, https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm |
| Headcount | 738 employees (2025-12-31) | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm, https://www.sec.gov/Archives/edgar/data/1124524/000110465926024180/cyrx-20251231x10k.htm |
| Certification | ISO 21973:2020 certification (2025-10-30) | https://ir.cryoportinc.com/news-events/press-releases/detail/402/cryoport-continues-to-set-new-benchmarks-for-the-global-regenerative-medicine-supply-chain, https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm, https://www.investing.com/news/company-news/cryoport-becomes-first-supply-chain-firm-to-achieve-iso-21973-certification-93CH-4319509 |
| Certification | ISO 9001:2015 certification | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm |
| Certification | ISO 13485:2016 certification (for medical devices) | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm |
| Regulatory approval | FDA registration and listing for MVE cryogenic freezers and dewars | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm |
| Production site | MVE manufacturing facilities in the United States and China | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm, https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001140361-26-016129/0001140361-26-016129.pdf |
| Production site | Global Supply Chain Center in Santa Ana, California | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001140361-26-016129/0001140361-26-016129.pdf |
| Production site | Global Supply Chain Center in Paris, France | https://ir.cryoportinc.com/news-events/press-releases/detail/402/cryoport-continues-to-set-new-benchmarks-for-the-global-regenerative-medicine-supply-chain, https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001140361-26-016129/0001140361-26-016129.pdf |
| Production site | BioServices operations in Liege, Belgium | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm, https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001140361-26-016129/0001140361-26-016129.pdf |
| Production site | CryoGene facilities in Houston, TX and San Antonio, TX | https://ir.cryoportinc.com/sec-filings/all-sec-filings/content/0001104659-26-024180/cyrx-20251231x10k.htm |

Independent sources: investing.com, sec.gov

## Technologies

- [Cryogenic equipment for biotech](https://en.bioecon.ru/technology/cryogenic-equipment-biotech/)
- [Hazardous biomaterials transport (IATA Class 6.2)](https://en.bioecon.ru/technology/hazardous-biomaterials-transport/)